-
NRXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
NRx Pharmaceuticals (NRXP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm |
Cash burn (monthly) | 84.00 k | 604.67 k | 1.01 mm | 1.71 mm | 768.67 k | 977.58 k |
Cash used (since last report) | 381.58 k | 2.75 mm | 4.58 mm | 7.75 mm | 3.49 mm | 4.44 mm |
Cash remaining | 1.26 mm | -1.10 mm | -2.93 mm | -6.11 mm | -1.85 mm | -2.79 mm |
Runway (months of cash) | 15.1 | -1.8 | -2.9 | -3.6 | -2.4 | -2.9 |
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 7 |
Closed positions | 11 |
Increased positions | 4 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.00 bn |
Total shares | 1.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Big Rock Partners Sponsor | 655.57 k | $15.90 mm |
BRAC Lending | 590.43 k | $14.32 mm |
Vanguard | 240.32 k | $406.13 mm |
Anson Funds Management | 142.53 k | $240.87 mm |
Geode Capital Management | 77.34 k | $130.73 mm |
TFC Truist Financial | 38.97 k | $1.75 mm |
Sabby Management | 35.05 k | $59.23 mm |
BlackRock | 29.08 k | $49.14 mm |
STT State Street | 16.72 k | $28.26 mm |
Wolverine Asset Management | 15.39 k | $692.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Feb 25 | Michael S Abrams | Stock Option Common Stock | Grant | Acquire A | No | No | 2.94 | 50,000 | 147.00 k | 50,000 |
17 Dec 24 | Javitt Jonathan C | Common Stock | Buy | Acquire P | No | No | 1.17 | 40,000 | 46.80 k | 84,634 |